Viewing nowAtorvastatin Tablets 20 mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Ilhwa Co., Ltd.

MFDS item code 201404537 · Approved 2014.09.30 · Insurance code 640902790
Improvement of hyperlipidemia; prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)
This medication helps reduce the risk of myocardial infarction, stroke, vascular surgery, and angina in adults with various risk factors for cardiovascular disease and patients with type 2 diabetes. In particular, it lowers the risk of non-fatal myocardial infarctions and strokes in patients with coronary artery disease, as well as the risk of hospitalization due to congestive heart failure. Additionally, this drug is effective in treating hyperlipidemia. It reduces cholesterol and triglyceride levels in patients with primary hypercholesterolemia and mixed dyslipidemia while increasing HDL cholesterol levels to complement dietary therapy. It is also used in patients with dyslipidemia or familial hypercholesterolemia who do not respond to dietary therapy. Furthermore, this medication is utilized to lower cholesterol levels in pediatric patients (ages 10 to 17) with heterozygous familial hypercholesterolemia. In summary, this medicine is effective for reducing the risk of cardiovascular disease and treating dyslipidemia.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. The medicine may be taken at any time of day, with or without food. Hyperlipidemia: The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45% or more is required). This medicine is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to the patient's characteristics, taking treatment goals and response into consideration. Lipid levels should be analyzed within 2 ~ 4 weeks after initiation of treatment and/or dose titration, and the dose adjusted accordingly. Patients with homozygous familial hypercholesterolemia: The dose of this medicine is 10 ~ 80 mg once daily. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. Older adults: Efficacy and safety in patients aged 70 years or older are generally similar to those in adult patients.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose of this medicine is 10 mg once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses higher than 20 mg in pediatric patients). Adjust the dose as appropriate according to the recommended treatment goals for each patient. Adjust the dose at intervals of 4 weeks or longer.
This medication may cause muscle-related symptoms, so if you experience severe muscle pain or weakness, you should immediately stop taking it and consult a physician. In particular, if muscle enzyme levels rise significantly or muscle disease is suspected, the medication should be discontinued. Patients with weakened kidney function due to severe infections or surgeries may need to temporarily stop taking the medication. This drug should not be used in patients with poor liver function or active liver disease. It should not be administered to pregnant women, women who may become pregnant, or breastfeeding women, as well as children under 10 years of age. You should also avoid taking this medication if you are allergic to any of its ingredients. Patients with a history of alcoholism or liver disease should use this medication with caution. Patients with impaired kidney function, hypothyroidism, or a history of muscle disorders should consult a physician before taking this medication. Elderly patients should be cautious as they have a higher risk of developing muscle disease. This medication can interact with various drugs, so if you are taking other medications, be sure to inform your doctor or pharmacist. In particular, dosage adjustments may be necessary when taken with certain antibiotics, antifungals, antivirals, or immunosuppressants. Grapefruit juice can increase the blood concentration of this medication, so excessive intake should be avoided. If you experience any symptoms of liver dysfunction or muscle pain, fatigue, fever, etc. while taking this drug, you should inform your physician immediately and undergo testing. Regular liver function tests and muscle enzyme tests are recommended while on this medication. Women who are pregnant should ensure adequate contraception and discontinue use if pregnancy is confirmed. Breastfeeding women should not take this medication and it is safer to stop breastfeeding. The safety and efficacy in children or the elderly have not been sufficiently confirmed, so you should follow your physician's advice. There is no specific antidote for overdose, so treatment should be based on symptoms while monitoring liver function and muscle status. Store this medication out of the reach of children, and keep it in the original container to maintain its quality.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a sealed container. The storage temperature should be kept at room temperature between 1 and 30 degrees Celsius to maintain its efficacy and safety over time.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Ilhwa Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.